Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Goodman

Showing results (651-660 of 696) with videos related to

Pageof 70
Sort By:
JAMA|February 14, 2013
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesDouglas R Morgan, Javier Torres, Rachael Sexton, et al.
Lancet (London, England)|July 23, 2011
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialE Robert Greenberg, Garnet L Anderson, Douglas R Morgan, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
JNCI Cancer Spectrum|May 30, 2024
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, et al.
Regulatory Toxicology and Pharmacology : RTP|March 26, 2004
A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteinsK Thomas, M Aalbers, G A Bannon, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2022
Considerations for the Use of Phage Therapy in Clinical PracticeGina A Suh, Thomas P Lodise, Pranita D Tamma, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Prostaglandins & Other Lipid Mediators|August 9, 2011
Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancerBrigette L Tippin, A Joan Levine, Alicia M Materi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer ConsortiumPawadee Lohavanichbutr, Lori C Sakoda, Christopher I Amos, et al.
Pageof 70

Showing results (651-660 of 696) with videos related to

Sort By:
Pageof 70
JAMA|February 14, 2013
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesDouglas R Morgan, Javier Torres, Rachael Sexton, et al.
Lancet (London, England)|July 23, 2011
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialE Robert Greenberg, Garnet L Anderson, Douglas R Morgan, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
JNCI Cancer Spectrum|May 30, 2024
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, et al.
Regulatory Toxicology and Pharmacology : RTP|March 26, 2004
A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteinsK Thomas, M Aalbers, G A Bannon, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2022
Considerations for the Use of Phage Therapy in Clinical PracticeGina A Suh, Thomas P Lodise, Pranita D Tamma, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Prostaglandins & Other Lipid Mediators|August 9, 2011
Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancerBrigette L Tippin, A Joan Levine, Alicia M Materi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer ConsortiumPawadee Lohavanichbutr, Lori C Sakoda, Christopher I Amos, et al.
Pageof 70